Arrowhead Pharmaceuticals says it has reached a licensing and collaboration agreement with Janssen Pharmaceuticals that will bring the company $250 million to start and ultimately could be worth as much as $3.7 billion. Janssen will get the worldwide exclusive license for ARO-HBV, a drug that treats...
An influenza vaccine developed by FluGen, of Madison, is being tested on children and teenagers in a clinical trial that’s being subsidized by a division of the National Institutes of Health. The test began in August, according to a statement last week by the National Institute...
Discovery to Product, which supports and mentors faculty, staff and student innovators and entrepreneurs on campus, is offering a new program called Innovation to Market. The fall I2M program builds on the success of D2P’s Igniter program cohorts that helped start 19 companies over the...
A new study from NeuroPointDX of Madison and University of California researchers shows biochemical markers could allow for earlier identification of autism spectrum disorder. Lead author David Amaral says this discovery could also lead to avenues for therapeutic intervention. NeuroPointDX is a division of Stemina Biomarker Discovery,...
When Randy Nagy first envisioned a device to modernize the transport and protection of DNA samples, he already had more than two decades of experience in various aspects of DNA forensics. Amid the mushrooming legal and scientific interest in DNA analysis, Nagy obtained a patent on...
Every year, diarrheal disease kills more than 1 million people, mostly children in the developing world. To treat the illness effectively, health care providers need to know its cause. Currently, a diagnosis requires sending a stool sample to a lab for expensive tests, then waiting...
The Wisconsin Technology Council is recommending a host of policy changes in this year’s white papers report, including a new tax credit to incent employers to invest in their own workers. Some previous recommendations have recently been passed into law, including the expansion of the state’s...
Today’s groundbreaking of a 130,000 square-foot, five-story headquarters for Exact Sciences at University Research Park (URP) is further evidence of the cancer detection business’s commitment to Madison. But the building’s placement also shows that the Park is determined to adapt to an era when high-technology...
There are three main ways to detect colon cancer. A colonoscopy is accurate but expensive ($2,200 on average). A fecal immunochemical test, which looks for hidden blood in a stool sample, costs about $60 but is more likely to miss cancer and must be taken...
Two of the state’s newest venture capital funds are looking for big opportunities in health care technology. The Wisconsin Technology Council recently hosted a panel discussion spotlighting these funds. Panelists included George Arida, managing director for 30Ventures, based at University Research Park in Madison; and Mike...